# Trade Mark Journal No.2026/032 7 August 2026

## WO0000001913010 (5,42,44)

Office of origin: United States of America

Date of International Registration:20 February 2026
Date of designation in the UK: 20 February 2026

The mark consists of a stylized half sun above the stylized words SUNDANCE BIOSCIENCES.

International priority date claimed: 15 October 2025 (Jamaica) (0096018)

Class 5
  Pharmaceutical preparations for the treatment and prevention of immunological and neurological conditions, diseases, and disorders; biological preparations for the prevention and treatment of immunological and neurological conditions, diseases, and disorders.
Class 42
  Pharmaceutical and biological research and development; providing medical research information in the field of pharmaceuticals and biologics; providing scientific research information in the field of pharmaceuticals and biologics; all of the foregoing for the prevention and treatment of immunological and neurological conditions, diseases, and disorders.
Class 44
  Provision of medical information for the prevention and treatment of immunological and neurological conditions, diseases, and disorders.

Sundance Biosciences, Inc.

Representative: Kelley B. Harrington Cooley LLP, 1299 Pennsylvania Ave. NW STE 700, Washington DC 20004, UNITED STATES OF AMERICA